Abstract
1. This paper describes the evaluation of LY170680 (5-less than 3-[2(R) (carboxyethylthio)-(S)-hydroxypentadeca 3(E)5(Z)-dienyl]phenyl greater than 1H tetrazole, as an antagonist of the cysteinyl leukotrienes C4, D4, E4, in a variety of in vitro and in vivo models. 2. In vitro, LY170680 was a potent, selective, and competitive antagonist of LTD4, and LTE4. It produced a concentration-dependent rightward displacement of the concentration-response curves elicited by either LTD4 or LTE4 on both the guinea-pig ileal and tracheal preparation. The pA2 values for LY170680 were estimated to be 8.1 +/- 0.2 (n = 8) and 8.1 +/- 0.1 (n = 6) on trachea, and 8.7 +/- 0.1 (n = 12) and 9.0 +/- 0.3 (n = 6) on ileum for both LTD4 and LTE4 respectively. The slopes of the Schild plots in these studies were all close to unity. 3. LY170680 was shown to be a modest antagonist of the LTC4-induced responses on guinea-pig ileum (pA2 7.0 +/- 0.2 n = 5), but had no discernable effects against contractions induced by histamine, prostaglandin E2 (PGE2), PGF2 alpha or acetylcholine. The compound also reduced the LTC4-induced responses on trachea, but in a non competitive manner. 4. Intravenous LY170680 reduced in a dose-dependent manner (ED50 3.8 mg kg-1, 60 min pretreatment) the fall in compliance in the anaesthetized guinea-pig, and the rise in total pulmonary resistance (TPR) (ED50 2.0 mg kg-1, 30 min pretreatment) in the artificially ventilated guinea-pig, produced by intraveous LTD4.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AMDUR M. O., MEAD J. Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol. 1958 Feb;192(2):364–368. doi: 10.1152/ajplegacy.1958.192.2.364. [DOI] [PubMed] [Google Scholar]
- ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anderson W. H., O'Donnell M., Simko B. A., Welton A. F. An in vivo model for measuring antigen-induced SRS-A-mediated bronchoconstriction and plasma SRS-A levels in the guinea-pig. Br J Pharmacol. 1983 Jan;78(1):67–74. doi: 10.1111/j.1476-5381.1983.tb09363.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clay T. P., Miller P., Stead H. A lung perfusion technique for the detection of antigenic intrapulmonary bronchoconstriction and its mediation. J Pharmacol Methods. 1985 Nov;14(3):169–179. doi: 10.1016/0160-5402(85)90030-0. [DOI] [PubMed] [Google Scholar]
- Fleisch J. H., Rinkema L. E., Haisch K. D., Swanson-Bean D., Goodson T., Ho P. P., Marshall W. S. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J Pharmacol Exp Ther. 1985 Apr;233(1):148–157. [PubMed] [Google Scholar]
- Holroyde M. C., Altounyan R. E., Cole M., Dixon M., Elliott E. V. Bronchoconstriction produced in man by leukotrienes C and D. Lancet. 1981 Jul 4;2(8236):17–18. doi: 10.1016/s0140-6736(81)90254-3. [DOI] [PubMed] [Google Scholar]
- Ibe B. O., Campbell W. B. Synthesis and metabolism of leukotrienes by human endothelial cells: influence on prostacyclin release. Biochim Biophys Acta. 1988 Jun 15;960(3):309–321. doi: 10.1016/0005-2760(88)90039-2. [DOI] [PubMed] [Google Scholar]
- Leitch A. G., Austen K. F., Corey E. J., Drazen J. M. Effects of indomethacin on the guinea-pig pulmonary response to intravenous leukotrienes C4 and D4. Clin Sci (Lond) 1983 Sep;65(3):281–287. doi: 10.1042/cs0650281. [DOI] [PubMed] [Google Scholar]
- Lewis R. A., Drazen J. M., Figueiredo J. C., Corey E. J., Austen K. F. A review of recent contributions on biologically active products of arachidonate conversion. Int J Immunopharmacol. 1982;4(2):85–90. doi: 10.1016/0192-0561(82)90055-8. [DOI] [PubMed] [Google Scholar]
- Marom Z., Shelhamer J. H., Bach M. K., Morton D. R., Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis. 1982 Sep;126(3):449–451. doi: 10.1164/arrd.1982.126.3.449. [DOI] [PubMed] [Google Scholar]
- Orehek J., Douglas J. S., Lewis A. J., Bouhuys A. Prostaglandin regulation of airway smooth muscle tone. Nat New Biol. 1973 Sep 19;245(142):84–85. doi: 10.1038/newbio245084a0. [DOI] [PubMed] [Google Scholar]
- Payne A. N., de Nucci G. Anaphylaxis in guinea pigs induced by ovalbumin aerosol in vivo and in vitro methods. J Pharmacol Methods. 1987 Mar;17(1):83–90. doi: 10.1016/0160-5402(87)90040-4. [DOI] [PubMed] [Google Scholar]
- Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
- Stengel P. W., Pechous P. A., Silbaugh S. A. Mechanism of A23187-induced airway obstruction in the guinea pig. Prostaglandins. 1987 Apr;33(4):567–577. doi: 10.1016/0090-6980(87)90280-2. [DOI] [PubMed] [Google Scholar]
- Weichman B. M., Muccitelli R. M., Osborn R. R., Holden D. A., Gleason J. G., Wasserman M. A. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig. J Pharmacol Exp Ther. 1982 Jul;222(1):202–208. [PubMed] [Google Scholar]
- Weiss J. W., Drazen J. M., Coles N., McFadden E. R., Jr, Weller P. F., Corey E. J., Lewis R. A., Austen K. F. Bronchoconstrictor effects of leukotriene C in humans. Science. 1982 Apr 9;216(4542):196–198. doi: 10.1126/science.7063880. [DOI] [PubMed] [Google Scholar]
- Woodward D. F., Weichman B. M., Gill C. A., Wasserman M. A. The effect of synthetic leukotrienes on tracheal microvascular permeability. Prostaglandins. 1983 Jan;25(1):131–142. doi: 10.1016/0090-6980(83)90142-9. [DOI] [PubMed] [Google Scholar]
